Recursion Pharmaceuticals stockRXRX
Recursion Pharmaceuticals trades at $3.50, 33.2% below its 52-week high (Jan 22, 2026). The price is below its 50- and 200-day averages, a downtrend. −14.4% year to date, −29.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 3, 2027.
Ratings, candles, signals and the screener for RXRX — after you log in
Open the terminalFrequently asked questions about Recursion Pharmaceuticals
What is the Recursion Pharmaceuticals stock price?
At the close on Nov 5, 2026: $3.50 (−9.79% on the day). 52-week high: $5.24 on Jan 22, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Recursion Pharmaceuticals report earnings?
The next quarterly report is on Mar 3, 2027. Last quarter, earnings per share changed +39% year over year, revenue +262%.
Does Recursion Pharmaceuticals pay dividends?
No, Recursion Pharmaceuticals does not pay dividends.
Where does Recursion Pharmaceuticals trade and how to buy it?
Ticker RXRX, exchange Nasdaq, listed since 2021. You can buy it through a broker with access to US exchanges.
Should I buy Recursion Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RXRX are in the terminal after you log in.